NMDA Receptors

Items 1-50 of 62

per page
Set Descending Direction
Catalog No.
Product Name
Product Information
Product Citation
  1. NMDA antagonist

    Non-opioid analgesic with muscle relaxant properties.
  2. NMDA receptor antagonist

    Memantine hydrochloride is an antagonist at the NMDA receptor, binding to the ion channel site. it was used in the treatment of Parkinsonism.
  3. NMDA receptor antagonist

    Orphenadrine citrate is a NMDA receptor antagonist with Ki of 6.0 +/- 0.7 μM, HERG potassium channel blocker.
  4. Felbamate is an antagonist at the NMDA-associated glycine binding site.
  5. NMDA Receptor Antagonist

    TCN 201 is a NMDA receptor antagonist selective for NR1/NR2A over NR1/NR2B-containing receptors
  6. NMDA receptor antagonist

    SDZ 220-581 is a competitive NMDA receptor antagonist (pKi = 7.7).
  7. NMDA receptor agonist

    NMDA is a prototypic NMDA receptor agonist.
  8. NMDAR modulator

    GNE 0723 is a brain permeable positive allosteric modulator of NMDAR, with an EC50 of 21 nM for GluN2A, 7.4 and 6.2 μM for GluN2C and GluN2D, respectively.
  9. NMDA receptor antagonist

    (+)-MK 801 is a potent antagonist of NMDA with Ki value of 30.5nM.
  10. NMDA antagonist

    Eliprodil is a non-competitive NR2B-NMDA receptor antagonist(IC50=1 uM), less potent for NR2A- and NR2C-containing receptors(IC50> 100 uM).
  11. NMDA receptors Blocker

    Ro 25-6981 is a high-affinity, potent and selective blocker of N-methyl- D-aspartate (NMDA) receptors.
  12. NMDA receptor antagonist

    RPR104632 is a specific antagonist of NMDA receptor, with potent neuroprotective properties.
  13. NMDA receptor antagonist.

    (-)-MK 801 maleate acts as a potent, selective, and non-competitive NMDA receptor antagonist. It acts by binding to a site located within the NMDA associated ion channel.
  14. NMDA receptor antagonist

    GV-196771A is the sodium salt form of GV196771, is an NMDA receptor antagonist.
  15. NMDAR modulator

    GLYX-13 is a selective weak partial agonist of the glycine site of the NMDA receptor which is under development by Naurex as adjunctive therapy for treatment-resistant depression.
  16. NMDA receptor antagonist

    MDL-29951 is a novel glycine antagonist of NMDA receptor activation (Ki=0.14 mM, [3H]glycine binding) in vitro and in vivo.
  17. NMDA receptor ion channel antagonist

    ARL-15896 is a novel N-methyl-D-aspartate receptor ion channel antagonist.
  18. NMDA receptor antagonist

    DNQX is a non-N-methyl-D-aspartate (non-NMDA) receptor complex antagonist.
  19. NMDA& mGlu receptor agonist

    Ibotenic acid is a neuroexcitatory amino acid originally isolated from Amanita species that functions as a NMDA and metabotropic glutamate receptor agonist.
  20. NMDA receptors antagonist

    NVP-AAM077 inhibited progenitor cells proliferation in the subventricular zone and dentate gyrus and reduced the survival of newborn cells in the dentate gyrus in the adult mice.
  21. NMDA receptor antagonist

    SDZ 220-581 ammonium salt is a potent, competitive antagonist at the NMDA glutamate receptor subtype(pKi= 7.7).
  22. glutamate receptors agonist

    (S)-Glutamic acid acts as an excitatory transmitter and an agonist at all subtypes of glutamate receptors (metabotropic, kainate, NMDA, and AMPA).
  23. NMDA/glycine receptor antagonist

    L-701324 is an orally active and long acting anticonvulsant with high affinity and selectivity for the glycine site on the NMDA receptor,
  24. NMDA receptors Potentiator

    CIQ is a subunit-selective potentiator of NMDA receptors containing the NR2C or NR2D subunit.
  25. NMDA antagonist

    CGS 19755 (cis-4-phosphonomethyl-2-piperidine carboxylic acid) was found to be a potent, stereospecific inhibitor of N-methyl-D-aspartate (NMDA)-evoked, but not KCl-evoked, [3H] acetylcholine release from slices of the rat striatum.
  26. NMDA receptors blocker

    Ro 25-6981 Maleate is a potent and selective activity-dependent blocker of NMDA receptors containing the NR2B subunit. IC50 values are 0.009 and 52 uM for cloned receptor subunit combinations NR1C/NR2B and NR1C/NR2A respectively.
  27. AMPA/kainate antagonist

    CNQX is a competitive, non-NMDA glutamate receptor antagonist (IC50s = 0.3 and 1.5 uM for AMPA and kainate receptors, respectively, versus IC50 = 25 uM for NMDA receptors).
  28. NMDA receptor antagonist

    Ifenprodil tartrate is the atypical N-methyl-D-aspartate (NMDA) receptor antagonist, inhibits NMDA-induced currents at NR1A/NR2B receptors with high affinity (IC50 = 0.34 μM).
  29. excitatory transmitter/agonist

    L-Glutamic acid monosodium salt acts as an excitatory transmitter and an agonist at all subtypes of glutamate receptors (metabotropic, kainate, NMDA, and AMPA). (S)-Glutamic acid shows a direct activating effect on the release of DA from dopaminergic terminals.
  30. GlyT inhibitor/NMDA receptor

    Sarcosine is a glycine transporter type 1 (GlyT) inhibitor and an N-methyl-D-aspartate (NMDA) receptor co-agonist at the glycine binding site.
  31. NMDA receptor antagonist

    Neu-2000 is a NMDA receptor antagonist potentially for the treatment of stroke.
  32. NMDA antagonist

    D-AP5 is a selective N-methyl-D-aspartate (NMDA) receptor antagonist that competitively inhibits the glutamate binding site of NMDA receptors.
  33. NMDA receptor antagonist

    7CKA is a NMDA receptor antagonist that acts at the glycine site.
  34. Muscarinic antagonist

    Procyclidine hydrochloride is a muscarinic antagonist that crosses the blood-brain barrier and is used in the treatment of drug-induced extrapyramidal disorders and in Parkinsonism.
  35. NMDA receptor antagonist

    Mephenesin is an NMDA receptor antagonist, is a centrally acting muscle relaxant.
  36. NMDA antagonist

    AZD-4282, also known as aminoacetic acid and glycine, is a N-methyl-D-aspartate (NMDA) receptor antagonist potentially for the treatment of neuropathic pain.
  37. NMDA glutamate receptor co-agonist

    (R)-Serine, an endogenous amino acid involved in glia-synapse interactions that has unique neurotransmitter characteristics, is a potent co-agonist at the NMDA glutamate receptor.
  38. NMDA channel blocker

    Lanicemine (AZD6765) is a low-trapping NMDA channel blocker with a binding (Ki) of 0.56-2.1?μM.
  39. GluN2B modulator

    BMS-986163 is a negative allosteric modulator of GluN2B. The prodrug BMS-986163 rapidly converts to its active parent molecule BMS-986169 (Ki=4 nM, IC50=24 nM).
  40. NMDA receptor partial agonist

    Apimostinel (NRX-1074; AGN-241660) is an orally active NMDA receptor partial agonist.
  41. NMDA receptor (glycineB) antagonist

    MRZ 2-514 is an antagonist of the strychnine-insensitive modulatory site of the NMDA receptor (glycineB), with Ki of 33 μM.
  42. NMDAR modulator

    GNE 5729 is a brain permeable positive allosteric modulator of NMDAR, with an EC50 of 37 nM for GluN2A, 4.7 and 9.5 μM for GluN2C and GluN2D, respectively.
  43. NMDA ion-channel antagonist

    CNS-5161 hydrochloride is a novel NMDA ion-channel antagonist that interacts with the NMDA receptor/ion channel site to produce a noncompetitive blockade of the actions of glutamate.
  44. kainate receptors agonist

    SYM 2081 is a high-affinity ligand and potent, selective agonist of kainate receptors, inhibits [3H]-kainate binding with an IC50 of 35 nM, almost 3000- and 200-fold selectivity for kainate receptors over AMPA and NMDA receptors respectively.
  45. PSD95-nNOS interactions inhibitor

    IC87201, an inhibitor of PSD95-nNOS protein-protein interactions, suppresses NMDAR-dependent NO and cGMP formation.
  46. nNOS/PSD-95 interaction inhibitor

    ZL006 is a potent inhibitor of nNOS/PSD-95 interaction, and inhibits NMDA receptor-mediated NO synthesis.
  47. DL-AP5 is the racemic version of the selective N-methyl-D-aspartate (NMDA) receptor antagonist.
  48. NMDA receptor agonist

    Quinolinic acid is an endogenous N-methyl-D-aspartate (NMDA) receptor agonist synthesized from L-tryptophan via the kynurenine pathway and thereby has the potential of mediating N-methyl-D-aspartate neuronal damage and dysfunction.
  49. NMDA receptor antagonist

    Perzinfotel (EAA-090) is a potent, selective, and competitive NMDA receptor antagonist with neuroprotective effects. Perzinfotel (EAA-090) shows high affinity (IC50=30 nM) for the glutamate site.
  50. NMDA antagonist

    UK-240455 is a potent and selective N-methyl D-aspartate (NMDA) glycine site antagonist.

Items 1-50 of 62

per page
Set Descending Direction